281 related articles for article (PubMed ID: 10508165)
41. p27 and cyclin E/D2 associations in testicular germ cell tumors: implications for tumorigenesis.
Kukoski R; Blonigen B; Macri E; Renshaw AA; Hoffman M; Loda M; Datta MW
Appl Immunohistochem Mol Morphol; 2003 Jun; 11(2):138-43. PubMed ID: 12777997
[TBL] [Abstract][Full Text] [Related]
42. The functions of Myc in cell cycle progression and apoptosis.
Steiner P; Rudolph B; Müller D; Eilers M
Prog Cell Cycle Res; 1996; 2():73-82. PubMed ID: 9552384
[TBL] [Abstract][Full Text] [Related]
43. Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.
Khan F; Ricks-Santi LJ; Zafar R; Kanaan Y; Naab T
Ann Diagn Pathol; 2018 Jun; 34():170-174. PubMed ID: 29715580
[TBL] [Abstract][Full Text] [Related]
44. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.
Susaki E; Nakayama K; Nakayama KI
Mol Cell Biol; 2007 Jul; 27(13):4626-40. PubMed ID: 17452458
[TBL] [Abstract][Full Text] [Related]
45. Repression of cyclin D1: a novel function of MYC.
Philipp A; Schneider A; Väsrik I; Finke K; Xiong Y; Beach D; Alitalo K; Eilers M
Mol Cell Biol; 1994 Jun; 14(6):4032-43. PubMed ID: 8196642
[TBL] [Abstract][Full Text] [Related]
46. Identification of CDK4 as a target of c-MYC.
Hermeking H; Rago C; Schuhmacher M; Li Q; Barrett JF; Obaya AJ; O'Connell BC; Mateyak MK; Tam W; Kohlhuber F; Dang CV; Sedivy JM; Eick D; Vogelstein B; Kinzler KW
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2229-34. PubMed ID: 10688915
[TBL] [Abstract][Full Text] [Related]
47. Mouse embryo fibroblasts: a genetic model system for studying Rho- and Ras-dependent cell cycle progression.
D'Abaco GM; Olson MF
Methods Enzymol; 2000; 325():415-25. PubMed ID: 11036623
[No Abstract] [Full Text] [Related]
48. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.
de Alboran IM; O'Hagan RC; Gärtner F; Malynn B; Davidson L; Rickert R; Rajewsky K; DePinho RA; Alt FW
Immunity; 2001 Jan; 14(1):45-55. PubMed ID: 11163229
[TBL] [Abstract][Full Text] [Related]
49. Increased apoptosis in differentiating p27-deficient mouse embryonic stem cells.
Bryja V; Pacherník J; Soucek K; Horvath V; Dvorák P; Hampl A
Cell Mol Life Sci; 2004 Jun; 61(11):1384-400. PubMed ID: 15170516
[TBL] [Abstract][Full Text] [Related]
50. p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs.
Prathapam T; Aleshin A; Guan Y; Gray JW; Martin GS
J Biol Chem; 2010 Oct; 285(42):32529-38. PubMed ID: 20647308
[TBL] [Abstract][Full Text] [Related]
51. Multiple mechanisms for p27(Kip1) translocation and degradation.
Susaki E; Nakayama KI
Cell Cycle; 2007 Dec; 6(24):3015-20. PubMed ID: 18075313
[TBL] [Abstract][Full Text] [Related]
52. Redox regulation of cardiomyocyte cell cycling via an ERK1/2 and c-Myc-dependent activation of cyclin D2 transcription.
Murray TV; Smyrnias I; Schnelle M; Mistry RK; Zhang M; Beretta M; Martin D; Anilkumar N; de Silva SM; Shah AM; Brewer AC
J Mol Cell Cardiol; 2015 Feb; 79():54-68. PubMed ID: 25450615
[TBL] [Abstract][Full Text] [Related]
53. [Activity of c-myc protein is necessary in the first 6 hours of the prereplicative period for 3T3 Swiss cells].
Egorov EE; Sullivan NF; Cremisi C; Lyne L
Mol Biol (Mosk); 1994; 28(1):127-36. PubMed ID: 8145740
[TBL] [Abstract][Full Text] [Related]
54. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.
Coller HA; Grandori C; Tamayo P; Colbert T; Lander ES; Eisenman RN; Golub TR
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3260-5. PubMed ID: 10737792
[TBL] [Abstract][Full Text] [Related]
55. GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN.
Huang W; Chang HY; Fei T; Wu H; Chen YG
Oncogene; 2007 Apr; 26(17):2471-82. PubMed ID: 17043650
[TBL] [Abstract][Full Text] [Related]
56. Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Bahram F; Hydbring P; Tronnersjö S; Zakaria SM; Frings O; Fahlén S; Nilsson H; Goodwin J; von der Lehr N; Su Y; Lüscher B; Castell A; Larsson LG
Oncotarget; 2016 Jan; 7(3):2837-54. PubMed ID: 26701207
[TBL] [Abstract][Full Text] [Related]
57. Participation of cyclin A in Myc-induced apoptosis.
Hoang AT; Cohen KJ; Barrett JF; Bergstrom DA; Dang CV
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6875-9. PubMed ID: 8041712
[TBL] [Abstract][Full Text] [Related]
58. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
Jackstadt R; Hermeking H
Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
[TBL] [Abstract][Full Text] [Related]
59. USP12 regulates cell cycle progression by involving c-Myc, cyclin D2 and BMI-1.
Tang LJ; Li Y; Liu YL; Wang JM; Liu DW; Tian QB
Gene; 2016 Mar; 578(1):92-9. PubMed ID: 26680102
[TBL] [Abstract][Full Text] [Related]
60. Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells.
La T; Chen S; Guo T; Zhao XH; Teng L; Li D; Carnell M; Zhang YY; Feng YC; Cole N; Brown AC; Zhang D; Dong Q; Wang JY; Cao H; Liu T; Thorne RF; Shao FM; Zhang XD; Jin L
Theranostics; 2021; 11(19):9605-9622. PubMed ID: 34646389
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
